Bridge GLP compliant drug development in the US & China
Articles
Offshore Opportunity on the Rise
Mar 1, 2008 |
By:Jim Miller |
BioPharm International |
China continues to get a lot of bad press for quality problems with some medications and other consumer products manufactured there, but its popularity as a place to conduct biopharmaceutical research continues to grow. The major clinial research organizations (CROs) are racing to get established there, as much to stay a step ahead of the competition as for the immediate opportunity. Read more...